YASO THERAPEUTICS INCORPORATED — Federal Contracts, Awards & Government Contractor Profile

About YASO THERAPEUTICS INCORPORATED

Yaso Therapeutics is a biotechnology company developing a non-hormonal contraceptive and antiviral drug platform using nanotechnology. The company is conducting a Phase 1 clinical trial for its patented drug, PPCM, which has potential applications in preventing and treating drug-resistant pathogens.

Development of non-hormonal contraceptive solutionsCreation of antiviral and antibacterial drug platformsUtilization of nanotechnology for drug deliveryConducting clinical trials (Phase 1)Research and development of multipurpose drug platforms

Is this your company?

Claim YASO THERAPEUTICS INCORPORATED to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim YASO THERAPEUTICS INCORPORATED & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.